Synthesis of Unusually Substituted Ureas
1
230 °C. H NMR (CDCl3): δ = 1.23 [s, 9 H, (CH3)3], 2.43 [s, 9 H,
acetylacetonate (72 mg, 0.27 mmol) was dissolved in anhydrous
(CH3)3], 7.32–7.92 (m, 7 H, CHarom.), 7.62 (s, 1 H, CH sp3), 9.41 THF (50 mL). Compound 2a (183 mg, 0.54 mmol) was added as a
(s, 1 H, NH) ppm. 13C NMR (CDCl3): δ = 29.2, 30.8, 35.9, 36.4,
solid to this blue solution, and the color changed instantaneously
to green. Upon stirring for 24 h a white precipitate formed, which
66.9, 122.2, 122.4, 125.6, 126.0, 127.6, 128.7, 129.2, 129.5, 134.1,
135.2, 150.1, 159.2, 165.8, 175.0 ppm. IR (ATR): ν = 1524 (vs), was then collected, washed with THF and dried in vacuo. Crystals
˜
1673 (vs), 3147 (br., NH) cm–1. MS (DCI): m/z (%) = 454 (100)
[C23H27N5OS2 + 1]+. C23H27N5OS2 (453.2): calcd. C 60.90, H 6.00,
N 15.44, S 14.14; found C 60.98, H 5.88, N 15.68, S 14.42.
suitable for X-ray analysis were obtained by slow solvent evapora-
tion of a solution of 8 in chloroform/ethanol. Yield: 42 mg (21%);
m.p. 260 °C. IR (ATR): ν = 708, 724 (s), 743, 755, 810, 873, 1122,
˜
1179, 1186, 1337, 1368, 1399, 1459, 1599, 1622 (vs), 2905 (w), 2990
2-Butyl-5-methyl-N-(5-methyl-1,3,4-thiadiazol-2-yl)-1,3,4-thia-
diazol-3(2H)-carboxamide (2e): Yield: 2.66 g (89%); m.p. 115 °C.
1H NMR (CDCl3): δ = 0.89 (t, 3 H, CH3), 1.29 (m, 4 H, CH2),
1.81/1.97 (m, 2 H, CH2), 2.20 (s, 3 H, CH3), 2.65 (s, 3 H, CH3),
5.96 (q, 1 H, CH), 9.41 (s, 1 H, NH) ppm. 13C NMR (CDCl3): δ
= 13.9, 15.3, 16.6, 22.0, 26.6, 36.9, 69.4, 149.9, 151.7, 159.6,
(w), 3052 (w) cm–1. MS (micro-ESI in methanol/THF): m/z (%) =
1479 (2) [C56H56Cu2N20O4S8
+
23]+, 1124 (2), 750 (34)
[C28H28CuN10O2S4 + 23]+, 685(100). C56H58Cu2N20O5S8 (1474.8):
calcd. C 45.61, H 3.96, N 18.99, S 17.39; found C 45.24, H 4.16,
N 18.74, S 17.19.
159.8 ppm. IR (ATR): ν = 1525 (vs), 1663 (vs), 3150 (br., NH)
˜
X-ray Structure Determinations of 2a, 2b, 2g, 2h, and 8: The inten-
sity data for compounds 2a, 2b, 2g, 2h, and 8 were collected with
a Nonius-KappaCCD diffractometer by using graphite-monochro-
mated Mo-Kα radiation. Data were corrected for Lorentzian and
polarization effects but not for absorption effects.[20,21] The struc-
tures were solved by direct methods (SHELXS)[22] and refined by
cm–1. MS (DCI): m/z (%) = 300 (100) [C11H17N5OS2 + 1]+.
C11H17N5OS2 (299.4): calcd. C 44.13, H 5.72, N 23.39, S 21.42;
found C 44.11, H 5.75, N 23.41, S 21.30.
2-Butyl-5-isopropyl-N-(5-isopropyl-1,3,4-thiadiazol-2-yl)-1,3,4-thia-
1
diazol-3(2H)-carboxamide (2f): Yield: 2.63 g (74%); m.p. 68 °C. H
2
full-matrix least-squares techniques against Fo (SHELXL-97).[23]
NMR (CDCl3): δ = 0.88 (t, 3 H, CH3), 1.25 (d, 6 H, CH3), 1.33
(m, 4 H, CH2), 1.40 (d, 6 H, CH3), 1.86/1.93 (m, 2 H, CH2), 2.83
(m, 1 H, CH), 3.37 (m, 1 H, CH), 5.95 (q, 1 H, CH), 9.47 (s, 1 H,
NH) ppm. 13C NMR (CDCl3): δ = 14.0, 20.9, 21.0, 21.9, 23.1, 26.6,
For compounds 2a, 2b, and 2h the amine hydrogen atoms, for com-
pound 8 the hydrogen atoms of the water molecule, and for com-
pound 2g all hydrogen atoms were located by difference Fourier
synthesis and refined isotropically. The other hydrogen atoms were
included at calculated positions with fixed thermal parameters. All
non-hydrogen atoms were refined anisotropically.[23] XP (SIE-
MENS Analytical X-ray Instruments, Inc.) was used for structure
representations.
29.7, 30.3, 36.8, 68.3, 125.5, 150.1, 162.2, 171.6 ppm. IR (ATR): ν
˜
= 1527 (vs), 1671 (vs), 3119 (br., NH) cm–1. MS (EI): m/z (%) = 356
(100) [C15H25N5OS2 + 1]+. C15H25N5OS2 (355.4): calcd. C 50.67, H
7.09, N 19.70, S 18.04; found C 50.51, H 6.78, N 20.16, S 18.55.
2-(2-Hydroxyphenyl)-5-methyl-N-(5-methyl-1,3,4-thiadiazol-2-yl)-
1,3,4-thiadiazol-3(2H)-carboxamide (2g): Yield: 2.21 g (66%); m.p.
Supporting Information (see footnote on the first page of this arti-
cle): Crystal data and refinement details.
1
243 °C. H NMR (DMSO): δ = 2.21 (s, 3 H, CH3), 2.79 (s, 3 H,
CH3), 6.73-7.16 (m, 4 H, CHarom), 7.02 (s, 1 H, CH sp3), 10.01 (s,
1 H, OH), 11.31 (br., 1 H, NH) ppm. 13C NMR (DMSO): δ = 14.8,
16.2, 65.0, 115.3, 119.2, 124.3, 126.9, 129.3, 150.6, 153.0, 158.5,
Acknowledgments
160.3 171.1 ppm. IR (ATR): ν = 1457 (vs), 1528 (vs), 1681 (vs),
˜
3121 (br., NH), 3387 (s, OH) cm–1. MS (DCI): m/z (%) = 336 (40)
[C13H13N5O2S2 + 1]+. C13H13N5O2S2 (335.4): calcd. C 46.55, H
3.91, N 20.88, S 19.12; found C 46.44, H 4.02, N 20.77, S 19.05.
Financial support by the Deutsche Forschungsgemeinschaft (DFG
Bonn-Bad Godesberg; SFB 436) and the Fonds der Chemischen
Industrie (Germany) is gratefully acknowledged.
5-Ethyl-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-(2-hydroxyphenyl)-1,3,4-
thiadiazol-3(2H)-carboxamide (2h): Yield: 2.62 g (72 %); m.p.
209 °C. H NMR (DMSO): δ = 1.15 (t, 3 H, CH3), 1.23 (t, 3 H,
[1] E. Anders, K. Wermann, B. Wiedel, W. Günther, H. Görls, Eur.
J. Org. Chem. 1998, 2923–2930.
1
[2] E. Anders, K. Wermann, J. J. Vanden Eynde, Advances in Het-
erocyclic Chemistry: Chemistry of N-(1-Haloalkyl)Heteroaryl-
ium Salts (Ed.: A. R. Katritzky), Academic Press, New York,
2000, vol. 77, pp. 183–219 (Review Article).
[3] K. Wermann, M. Walther, W. Günther, H. Görls, E. Anders,
Eur. J. Org. Chem. 2003, 1389–1403.
CH3), 2.53 (q, 2 H, CH2), 2.91 (q, 2 H, CH2), 6.74 (t)/6.80 (d)/6.87
(d)/7.15 (t, 4 H, CHarom), 7.01 (s, 1 H, CH sp3), 10.08 (s, 1 H, OH),
11.3 (br., 1 H, NH) ppm. 13C NMR (DMSO): δ = 15.3, 16.4, 21.2,
22.1, 70.0, 116.7, 120.0, 124.4, 125.8, 129.7, 137.3, 150.6, 159.7,
159.8, 170.9 ppm. IR (ATR): ν = 1462 (vs), 1538 (vs), 1689 (vs),
˜
3090 (br., NH), 3381 (s, OH) cm–1. MS (DCI): m/z (%) = 364 (30)
[C15H17N5O2S2 + 1]+. C15H17N5O2S2 (363.5): calcd. C 49.57, H
4.71, N 19.27, S 17.64; found C 49.70, H 4.89, N 19.12, S 17.18.
[4] K. Wermann, M. Walther, E. Anders, ARKIVOC 2002, 10, 24–
33.
[5] M. Walther, K. Wermann, H. Görls, E. Anders, Synthesis 2001,
1327–1330.
5-tert-Butyl-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-2-(2-hydroxyphen-
yl)-1,3,4-thiadiazol-3(2H)-carboxamide (2i): Yield: 2.77 g (66%);
[6] K. Wermann, M. Walther, H. Görls, E. Anders, Synlett 2003,
1459–1462.
1
m.p. 254 °C. H NMR (DMSO): δ = 1.22 [s, 9 H, (CH3)3], 1.34 [s,
[7] K. Wermann, M. Walther, W. Günther, H. Görls, E. Anders,
Tetrahedron 2005, 61, 673–685.
9 H, (CH3)3], 6.74 (t)/6.78 (d)/6.83 (d)/7.14 (t, 4 H, CHarom), 7.01
(s, 1 H, CH sp3), 10.03 (s, 1 H, OH), 11.30 (br., 1 H, NH) ppm.
13C NMR (DMSO): δ = 28.8, 30.4, 35.3, 35.7, 64.5, 115.4, 119.2,
124.3, 127.0, 129.2, 150.7, 153.0, 159.8, 162.9, 172.8 ppm. IR
[8] S. O. N. Lill, G. Rauhut, E. Anders, Chem. Eur. J. 2003, 9,
3143–3153.
[9] M. Walther, K. Wermann, M. Lutsche, W. Günther, H. Görls,
E. Anders, J. Org. Chem. 2006, 71, 1399–1406.
[10] E. Anders, K. Wermann, B. Wiedel, J. J. Vanden Eynde, Liebigs
Ann./Recueil 1997, 745–752.
[11] E. Anders, J. G. Tropsch, A. R. Katritzky, D. Rasala, J. J.
Vanden Eynde, J. Org. Chem. 1989, 54, 4808–4812.
[12] E. Anders, A. Opitz, K. Wermann, B. Wiedel, M. Walther, W.
Imhof, H. Görls, J. Org. Chem. 1999, 64, 3113–3121.
(ATR): ν = 1454 (vs), 1522 (vs), 1691 (vs), 3079 (br., NH), 3390
˜
(OH) cm–1. MS (DCI): m/z (%) = 420 (100) [C19H25N5O2S2 + 1]+.
C19H25N5O2S2 (419.6): calcd. C 54.39, H 6.01, N 16.69, S 15.28;
found C 54.42, H 6.04, N 16.40, S 14.98.
[Cu2{5-methyl-2-(4-methylphenyl)-N-(5-methyl–1,3,4-thiadiazol-2-
yl)-1,3,4-thiadiazol-3(2H)-carboxamidato}4(H2O)] (8): Copper(II)
Eur. J. Org. Chem. 2009, 4143–4148
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4147